SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022660
Filing Date
2019-11-13
Accepted
2019-11-13 15:27:38
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20190930_10q.htm 10-Q 731670
2 EXHIBIT 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex_163217.htm EX-31.1 12848
3 EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICE ex_163218.htm EX-31.2 11850
4 EXHIBIT 32.1 CERTIFICATION OF PERIODIC REPORT CO-CEO ex_163219.htm EX-32.1 7055
5 EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT CFO ex_163220.htm EX-32.2 6156
  Complete submission text file 0001437749-19-022660.txt   4096465

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20190930.xml EX-101.INS 894785
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20190930.xsd EX-101.SCH 46187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20190930_cal.xml EX-101.CAL 42248
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20190930_def.xml EX-101.DEF 280174
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20190930_lab.xml EX-101.LAB 249895
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20190930_pre.xml EX-101.PRE 298983
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 191213537
SIC: 2834 Pharmaceutical Preparations